DOW JONES22,087.99+451.21 2.09%
S&P 5002,604.29+62.82 2.47%
NASDAQ7,709.26+206.89 2.76%

Calithera Biosciences Q4 EPS $(0.39) Misses $(0.37) Estimate

Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.37) by 5.41 percent. This is a 23.53 percent increase over losses of $(0.51) per share

Benzinga · 03/11/2020 20:11

Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.37) by 5.41 percent. This is a 23.53 percent increase over losses of $(0.51) per share from the same period last year.